What's new

FDA: Hospira Recalls 0.25% Marcaine (Bupivacaine HCl Injection, USP)
Apr 22, 2014    Advocacy & Practice Updates
Retina Radio Podcast: Jay S. Duker, MD, Discusses Defining Vitreoretinal Interface Diseases
Apr 22, 2014    Clinical Updates
FDA: Hospira Recalls 1% Lidocaine HCl Preservative-Free Injection
Apr 19, 2014    Advocacy & Practice Updates
CMS Urges ASRS to Share Names of Retina Specialists Inappropriately Terminated From Medicare Advantage Plans
Apr 15, 2014    Advocacy & Practice Updates
Advances Improve Management of Diabetic Retinal Detachments
Apr 15, 2014    Clinical Updates
Alimera Announces PDUFA Goal Date for Iluvien
Apr 15, 2014    Industry News
NCCI UPDATE - CMS to Resume Bundling Global Surgical Codes with Eye Visit Codes
Apr 11, 2014    Advocacy & Practice Updates
ASRS Cautions Patients Against Making Treatment Decisions Based Solely on CMS Payment Data
Apr 8, 2014    Advocacy & Practice Updates

Retina Times

2014 Spring Issue, Vol. 32, No. 1, Iss. 53




















In this issue:

From the President
Retina Specialists and the Hamster Wheel:
Will We Ever Reach the Finish Line?

Retinomics Perspectives
How Does Your Practice Divide Income?

Research & Development
Part 2 of 2: Exploring Dry-AMD Drugs in the Pipeline

Clinical Trials: Future Pathways
Clinical Trial Studies Combination Anti-VEGF and
Anti-Platelet-Derived Growth Factor for Exudative AMD

Pediatric Retina: Point/Counterpoint
Point: Telemedicine Is a Better ROP Screening Method
Counterpoint: I Think Telemedicine Is Great—I Just Don't Use It (for Now)

Ocular Imaging
Swept-Source OCT: What It Is and Why It Matters

Read all articles »